P Martin Petkovich

This inventor holds 33 USPTO granted patents and 11 published patent applications, plus 11 CIPO patents and 13 EPO patents, primarily in Vitamin D Therapy. Top assignees: Opko Ireland Global Holdings, Limited, Opko Renal, LLC, Eirgen Pharma Ltd.. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: P Martin Petkovich. Retrieved from https://idiyas.com/inventor/p-martin-petkovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 11)

% Patents Active = 84.8

CIPO Patents = 11 (Patent Applications = 9)

EPO Patents = 13 (Patent Applications = 21)

Average Co-Inventor Count = 4.4

ph-index = 11

Forward Citations = 253(Granted Patents)

Location History:

Ontario, CA (2000)
Kingston, CA (2001 - 2023)

Company Filing History:

13 out of 24

Opko Ireland Global Holdings, Limited

Queen's University at Kingston

Proventiv Therapeutics, LLC

patents

7. 2 out of 2

Opko IP Holdings Ii, Inc.

Johns Hopkins University

patents

10. 1 out of 1

Opko Ireland Global Hodlings, Ltd.

patent

11. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

Vitamin D Treatment

Chronic Kidney Disease

Parathyroid Levels

Controlled Release

Adjunctive Therapy

Vitamin D Insufficiency

Phosphate Management

1-deoxy Analogs

Retinoid Metabolizing Protein

Secondary Hyperparathyroidism

Vitamin D Derivatives

Oral Dosage

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12208106 - Methods of vitamin D treatment (2025-01-28),

2. 11752158 - Method of treating vitamin D insufficiency and deficiency (2023-09-12),

3. 11738033 - Adjunctive therapy with 25-hydroxyvitamin D and articles therefor (2023-08-29),

4. 11672809 - Methods and compositions for reducing parathyroid levels (2023-06-13),

5. 11452734 - Method of treating and preventing secondary hyperparathyroidism (2022-09-27),

6. 11173168 - Methods of treating vitamin D insufficiency in chronic kidney disease (2021-11-16),

7. 11154509 - Methods for controlled release oral dosage of a vitamin D compound (2021-10-26),

8. 11007205 - Adjunctive therapy with 25-hydroxyvitamin D and articles therefor (2021-05-18),

9. 10668089 - Method of treating and preventing secondary hyperparathyroidism (2020-06-02),

10. 10493084 - Adjunctive therapy with 25-hydroxyvitamin D and articles therefor (2019-12-03),

11. 10302660 - Methods useful for vitamin D deficiency and related disorders (2019-05-28),

12. 10220047 - Adjunctive therapy with 25-hydroxyvitamin D and articles therefor (2019-03-05),

13. 9925147 - Method for treating secondary hyperparathyroidism in CKD (2018-03-27),

14. 9918940 - Methods for controlled release oral dosage of a vitamin D compound (2018-03-20),

15. 9913852 - Method of treating and preventing secondary hyperparathyroidism (2018-03-13),

Title: P Martin Petkovich: Innovator in Vitamin D Treatments

Introduction

P Martin Petkovich, based in Kingston, CA, is a remarkable inventor known for his contributions to the field of medicine, particularly concerning vitamin D treatments. With a substantial portfolio of 33 patents, Petkovich's work has significantly impacted therapeutic approaches for vitamin D insufficiency and related conditions.

Latest Patents

Among his latest patents, Petkovich has developed innovative methods for vitamin D treatment, specifically focused on managing vitamin D insufficiency and secondary hyperparathyroidism in patients suffering from Chronic Kidney Disease (CKD). His patented methods include the administration of repeat doses of 25-hydroxyvitamin D, aiming to safely elevate serum levels above 90 ng/ml while maintaining the serum ratio of 25-hydroxyvitamin D to 24,25-dihydroxyvitamin D below 20. Furthermore, he has also introduced a method for treating vitamin D insufficiency and deficiency that emphasizes reducing toxicity associated with the administration of vitamin D3 and its derivatives.

Career Highlights

Petkovich's career is marked by key positions in notable organizations such as Opko Ireland Global Holdings and Opko Renal, LLC. His roles within these companies have provided him with a platform to research and develop his innovative therapeutic methods, pushing the boundaries of current medical practices in the field of vitamin D treatment.

Collaborations

Throughout his career, Petkovich has collaborated with esteemed colleagues, including Charles W Bishop and Jay A White. These partnerships have enhanced his research endeavors, fostering a collaborative spirit that is essential for groundbreaking advancements in medical innovation.

Conclusion

P Martin Petkovich stands out as a significant contributor to the field of vitamin D therapy. His 33 patents highlight his commitment to improving patient outcomes for those facing vitamin D-related health issues. With ongoing dedication to innovation and collaboration, Petkovich continues to pave the way for future advancements in medicine.

Profile summary based on public USPTO records.